119205-37-7

Basic information

• Product Name: 2-chlorocyclohex-1-enecarbonitrile
• Synonyms: 2-chlorocyclohex-1-enecarbonitrile;2-CHLOROCYCLOHEX-1-ENE-1-CARBONITRILE
• CAS NO: 119205-37-7
• Molecular Formula: C₇H₈ClN
• Molecular Weight: 141.59812
• Mol File: 119205-37-7.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-chlorocyclohex-1-enecarbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chlorocyclohex-1-enecarbonitrile(119205-37-7)
• EPA Substance Registry System: 2-chlorocyclohex-1-enecarbonitrile(119205-37-7)

Safety Data

• Hazardous Substances Data: 119205-37-7(Hazardous Substances Data)

Upstream product

• 4513-77-3 2-cyanocyclohexanone 
• 108-94-1 cyclohexanone 
• 1589-18-0 2-chloro-1-cyclohexene-aldoxime 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 312697-17-9 ethyl 3-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylate 
• 1380808-97-8 4-chloro-6,7,8,9-tetrahydrobenzo[1,2-d]pyrimidino[5,4-b]selenophene 
• 56475-13-9 2-chlorocyclohex-1-enylcarboxylic acid 

Relevant articles and documents

COMPOUNDS FOR TREATING VIRAL INFECTIONS

The present invention relates to small molecule compounds and their use in the treatment of diseases, in particular viral diseases, in particular hepatitis C virus (HCV).

Facile and efficient one-pot procedure for thieno[2,3-e][1,2,3]triazolo[1, 5-a]pyrimidines preparation

Base-catalyzed cycloaddition reactions of heterocyclic azides with activated nitriles were studied. Convenient, efficient, and high-yield synthetic method for thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines preparation from available starting reagents without complicated protocols was elaborated. Such an approach allows creation of broad combinatorial libraries for drug discovery. [Supplementary materials are available for this article. Go to the publisher's online edition of Synthetic Communications for the following free supplemental resource(s): Full experimental and spectral details.]

NOVEL ANTIVIRAL COMPOUNDS

The present invention relates to compounds of formula (A), as further defined herein, having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting 5 properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. The invention further relates to the use of such compounds, optionally combined with one or more other drugs having antiviral activity, for the treatment of animals suffering from viral infections, in particular HIV infection.